# 3594
Helen Branswell brings us a detailed story tonight on new hopes that a seed strain of the novel H1N1 virus, developed in a British Lab, may solve the low-yield problem that most manufacturers have been battling this summer.
Ms. Branswell is one of the best science reporters in the world, so I’ll simply get out of the way.
Follow the link to read the entire article.
Possible fix found for problem of low yield in pandemic vaccine production
By Helen Branswell Medical Reporter (CP)
A British laboratory may have found a fix for the low yield problem that has been plaguing companies making swine flu vaccine, a scientist from the lab revealed Wednesday.
John Wood of the U.K.'s National Institute for Biological Standards and Control said an improved version of the seed strain his lab produced in May seems to generate a virus yield that is on a par with what manufacturers get when they make seasonal flu vaccine.
While Wood cautioned the increased yield has to be confirmed by manufacturers, any improvement would be welcome news. Manufacturers have been clamouring for the new seed strain, which the lab started shipping out Wednesday.
